These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 35758271)
1. ABC transporters in breast cancer: their roles in multidrug resistance and beyond. Modi A; Roy D; Sharma S; Vishnoi JR; Pareek P; Elhence P; Sharma P; Purohit P J Drug Target; 2022 Nov; 30(9):927-947. PubMed ID: 35758271 [TBL] [Abstract][Full Text] [Related]
2. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420 [TBL] [Abstract][Full Text] [Related]
3. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547 [TBL] [Abstract][Full Text] [Related]
4. Differential expression and functionality of ATP-binding cassette transporters in the human hair follicle. Haslam IS; El-Chami C; Faruqi H; Shahmalak A; O'Neill CA; Paus R Br J Dermatol; 2015 Jun; 172(6):1562-1572. PubMed ID: 25418064 [TBL] [Abstract][Full Text] [Related]
5. Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells. Issa ME; Hall SR; Dupuis SN; Graham CL; Jakeman DL; Goralski KB Anticancer Drugs; 2014 Mar; 25(3):255-69. PubMed ID: 24231527 [TBL] [Abstract][Full Text] [Related]
6. Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer. Nedeljković M; Tanić N; Prvanović M; Milovanović Z; Tanić N Breast Cancer; 2021 May; 28(3):727-736. PubMed ID: 33420675 [TBL] [Abstract][Full Text] [Related]
7. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance. Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847 [TBL] [Abstract][Full Text] [Related]
8. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010 [TBL] [Abstract][Full Text] [Related]
9. Karanjin interferes with ABCB1, ABCC1, and ABCG2. Michaelis M; Rothweiler F; Nerreter T; Sharifi M; Ghafourian T; Cinatl J J Pharm Pharm Sci; 2014; 17(1):92-105. PubMed ID: 24735762 [TBL] [Abstract][Full Text] [Related]
10. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2. Shukla S; Robey RW; Bates SE; Ambudkar SV Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320 [TBL] [Abstract][Full Text] [Related]
11. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related]
12. Revisiting the role of ABC transporters in multidrug-resistant cancer. Robey RW; Pluchino KM; Hall MD; Fojo AT; Bates SE; Gottesman MM Nat Rev Cancer; 2018 Jul; 18(7):452-464. PubMed ID: 29643473 [TBL] [Abstract][Full Text] [Related]
13. Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression. Michaelis M; Rothweiler F; Nerreter T; van Rikxoort M; Zehner R; Dirks WG; Wiese M; Cinatl J BMC Res Notes; 2014 Oct; 7():710. PubMed ID: 25300205 [TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer. Chen Y; Bieber MM; Teng NN Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781 [TBL] [Abstract][Full Text] [Related]
15. ATP-binding cassette efflux transporters and MDR in cancer. Pote MS; Gacche RN Drug Discov Today; 2023 May; 28(5):103537. PubMed ID: 36801375 [TBL] [Abstract][Full Text] [Related]
16. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer. Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247 [TBL] [Abstract][Full Text] [Related]
17. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385 [TBL] [Abstract][Full Text] [Related]
18. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer. Kovalev AA; Tsvetaeva DA; Grudinskaja TV Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439 [TBL] [Abstract][Full Text] [Related]
19. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance. Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575 [TBL] [Abstract][Full Text] [Related]
20. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]